Cerenome, Inc. (CNSY) vs Phio Pharmaceuticals Corp. (PHIO)
A side-by-side comparison of Cerenome, Inc. and Phio Pharmaceuticals Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNSY
Cerenome, Inc.
$1.58HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
PHIO
Phio Pharmaceuticals Corp.
$0.99HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
Total return — CNSY vs PHIO
growth of $100 · dividends reinvested · last 1yCNSY -61.5% (-61.5%/yr)PHIO -0.9% (-0.9%/yr)PHIO compounded faster over this window
CNSY PHIO
CNSY vs PHIO: by the numbers
- •PHIO is the larger company ($11M vs $11M market cap).
- •Both run net losses; PHIO's is the smaller (0.00% vs -620.70% net margin).
Metrics side by side
Valuation
| Metric | CNSY | PHIO |
|---|---|---|
| P/S ratio | 2.59 | N/A |
| P/B ratio | 1.99 | 0.91 |
Profitability
| Metric | CNSY | PHIO |
|---|---|---|
| Gross margin | 89.58% | 0.00% |
| Operating margin | -293.46% | 0.00% |
| Net margin | -620.70% | 0.00% |
| ROE | -477.54% | -102.40% |
| ROIC | -479.39% | -100.51% |
Growth (annualized)
| Metric | CNSY | PHIO |
|---|---|---|
| Total return CAGR (5Y) | N/A | -65.73% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.